{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T16:16:21Z","timestamp":1788365781398,"version":"build-2803163510"},"reference-count":69,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"NINDS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100003188","name":"National Tay-Sachs and Allied Diseases Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100003188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009944","name":"ACVO Vision for Animals Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009944","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ymthe.2026.06.018","type":"journal-article","created":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T18:02:15Z","timestamp":1781200935000},"page":"5498-5509","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cerebrospinal delivery of a bidirectional AAV9 vector improves optic nerve and retinal pathology in a sheep model of Tay-Sachs disease"],"prefix":"10.1016","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9771-9294","authenticated-orcid":false,"given":"Brett D.","family":"Story","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara M.","family":"Thomasy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara A.","family":"Adelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toloo","family":"Taghian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvette","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Ardon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hikaru","family":"Shiraishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabina","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meher","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Do","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hector R.","family":"Benatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Bertrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Prestigiacomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachael","family":"Gately","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas R.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Sena-Esteves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangping","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leandro B.C.","family":"Teixeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian C.","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Marsh-Armstrong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather L.","family":"Gray-Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2026.06.018_bib1","doi-asserted-by":"crossref","first-page":"e1550","DOI":"10.1542\/peds.2006-0588","article-title":"The natural history of juvenile or subacute GM2 gangliosidosis: 21 new cases and literature review of 134 previously reported","volume":"118","author":"Maegawa","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymthe.2026.06.018_bib2","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/01.GIM.0000154300.84107.75","article-title":"Late-onset Tay-Sachs disease: phenotypic characterization and genotypic correlations in 21 affected patients","volume":"7","author":"Neudorfer","year":"2005","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymthe.2026.06.018_bib3","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/ng1095-170","article-title":"Mouse models of Tay-Sachs and Sandhoff diseases differ in neurologic phenotype and ganglioside metabolism","volume":"11","author":"Sango","year":"1995","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymthe.2026.06.018_bib4","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.ymgme.2010.08.006","article-title":"Tay-Sachs disease in Jacob sheep","volume":"101","author":"Torres","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymthe.2026.06.018_bib5","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1002\/glia.23641","article-title":"Hexb enzyme deficiency leads to lysosomal abnormalities in radial glia and microglia in zebrafish brain development","volume":"67","author":"Kuil","year":"2019","journal-title":"Glia"},{"key":"10.1016\/j.ymthe.2026.06.018_bib6","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1126\/science.404709","article-title":"GM2 ganglioside lysosomal storage disease in cats with beta-hexosaminidase deficiency","volume":"196","author":"Cork","year":"1977","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2026.06.018_bib7","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.expneurol.2017.09.012","article-title":"Murine Sialidase Neu3 facilitates GM2 degradation and bypass in mouse model of Tay-Sachs disease","volume":"299","author":"Seyrantepe","year":"2018","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ymthe.2026.06.018_bib8","article-title":"Temporary Efficacy of Pyrimethamine in Juvenile-Onset Tay-Sachs Disease Caused by 2 Unreported HEXA Mutations in the Indian Population","volume":"4","author":"Udwadia-Hegde","year":"2017","journal-title":"Child. Neurol. Open"},{"key":"10.1016\/j.ymthe.2026.06.018_bib9","series-title":"StatPearls (Treasure Island (FL)","article-title":"Tay-Sachs Disease","author":"Ramani","year":"2021"},{"key":"10.1016\/j.ymthe.2026.06.018_bib10","doi-asserted-by":"crossref","first-page":"34","DOI":"10.4103\/jovr.jovr_242_16","article-title":"Ophthalmologic Findings in Patients with Neuro-metabolic Disorders","volume":"13","author":"Jabbehdari","year":"2018","journal-title":"J. Ophthalmic Vis. Res."},{"key":"10.1016\/j.ymthe.2026.06.018_bib11","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.3389\/fphys.2018.01663","article-title":"New Approaches to Tay-Sachs Disease Therapy","volume":"9","author":"Solovyeva","year":"2018","journal-title":"Front. Physiol."},{"key":"10.1016\/j.ymthe.2026.06.018_bib12","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1056\/NEJMoa0802268","article-title":"Effect of gene therapy on visual function in Leber\u2019s congenital amaurosis","volume":"358","author":"Bainbridge","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2026.06.018_bib13","doi-asserted-by":"crossref","first-page":"15112","DOI":"10.1073\/pnas.0807027105","article-title":"Human gene therapy for RPE65 isomerase deficiency activates the retinoid cycle of vision but with slow rod kinetics","volume":"105","author":"Cideciyan","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2026.06.018_bib14","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1089\/hum.2008.107","article-title":"Treatment of leber congenital amaurosis due to RPE65 mutations by ocular subretinal injection of adeno-associated virus gene vector: short-term results of a phase I trial","volume":"19","author":"Hauswirth","year":"2008","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2026.06.018_bib15","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1089\/hum.2017.163","article-title":"Adeno-Associated Virus Gene Therapy in a Sheep Model of Tay-Sachs Disease","volume":"29","author":"Gray-Edwards","year":"2018","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2026.06.018_bib16","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.neuroscience.2016.10.047","article-title":"AAV-mediated gene delivery attenuates neuroinflammation in feline Sandhoff disease","volume":"340","author":"Bradbury","year":"2017","journal-title":"Neuroscience"},{"key":"10.1016\/j.ymthe.2026.06.018_bib17","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.expneurol.2014.09.020","article-title":"Biomarkers for disease progression and AAV therapeutic efficacy in feline Sandhoff disease","volume":"263","author":"Bradbury","year":"2015","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ymthe.2026.06.018_bib18","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1038\/mt.2013.86","article-title":"Therapeutic response in feline sandhoff disease despite immunity to intracranial gene therapy","volume":"21","author":"Bradbury","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.06.018_bib19","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/gt.2014.108","article-title":"Widespread correction of central nervous system disease after intracranial gene therapy in a feline model of Sandhoff disease","volume":"22","author":"McCurdy","year":"2015","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2026.06.018_bib20","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1038\/s41591-025-03822-4","article-title":"Dual-vector rAAVrh8 gene therapy for GM2 gangliosidosis: a phase 1\/2 trial","volume":"31","author":"Eichler","year":"2025","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2026.06.018_bib21","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/s41591-021-01664-4","article-title":"AAV gene therapy for Tay-Sachs disease","volume":"28","author":"Flotte","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2026.06.018_bib22","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1016\/j.ymthe.2020.06.021","article-title":"Pronounced Therapeutic Benefit of a Single Bidirectional AAV Vector Administered Systemically in Sandhoff Mice","volume":"28","author":"Lahey","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.06.018_bib23","doi-asserted-by":"crossref","DOI":"10.1172\/JCI182942","article-title":"Five-year analysis of efficacy and safety of a bidirectional AAV gene therapy in Tay-Sachs sheep","volume":"135","author":"Taghian","year":"2025","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymthe.2026.06.018_bib24","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/S0161-6420(84)34274-9","article-title":"Gangliosidoses and the fetal retina","volume":"91","author":"Cogan","year":"1984","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ymthe.2026.06.018_bib25","unstructured":"Yanoff, M. S. Ocular Pathology. Seventh Edition, 407\u2013410 (2014)."},{"key":"10.1016\/j.ymthe.2026.06.018_bib26","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/BF00690376","article-title":"Retinal amacrine cell involvement in Tay-Sachs disease","volume":"53","author":"Nagashima","year":"1981","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.ymthe.2026.06.018_bib27","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1136\/bjo.52.12.898","article-title":"Ultrastructure of the retina in Tay-Sach\u2019s disease","volume":"52","author":"Harcourt","year":"1968","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.ymthe.2026.06.018_bib28","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1354\/vp.38-3-281","article-title":"GM1-gangliosidosis in Alaskan huskies: clinical and pathologic findings","volume":"38","author":"M\u00fcller","year":"2001","journal-title":"Vet. Pathol."},{"key":"10.1016\/j.ymthe.2026.06.018_bib29","first-page":"675","article-title":"Canine GM1-gangliosidosis. A clinical, morphologic, histochemical, and biochemical comparison of two different models","volume":"140","author":"Alroy","year":"1992","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ymthe.2026.06.018_bib30","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s004010050955","article-title":"Naturally occurring GM2 gangliosidosis in two Muntjak deer with pathological and biochemical features of human classical Tay-Sachs disease (type B GM2 gangliosidosis)","volume":"97","author":"Fox","year":"1999","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.ymthe.2026.06.018_bib31","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1111\/jvim.14794","article-title":"GM2 Gangliosidosis in Shiba Inu Dogs with an In-Frame Deletion in HEXB","volume":"31","author":"Kolicheski","year":"2017","journal-title":"J. Vet. Intern. Med."},{"key":"10.1016\/j.ymthe.2026.06.018_bib32","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s001140050741","article-title":"Pathological alterations typical of human Tay-Sachs disease, in the retina of a deep-sea fish","volume":"87","author":"Fishelson","year":"2000","journal-title":"Naturwissenschaften"},{"key":"10.1016\/j.ymthe.2026.06.018_bib33","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.2460\/ajvr.1978.39.07.1137","article-title":"Quantitative study of the decussating optic axons in the pony, cow, sheep, and pig","volume":"39","author":"Herron","year":"1978","journal-title":"Am. J. Vet. Res."},{"key":"10.1016\/j.ymthe.2026.06.018_bib34","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1177\/0300985810388522","article-title":"Pathology of GM2 gangliosidosis in Jacob sheep","volume":"48","author":"Porter","year":"2011","journal-title":"Vet. Pathol."},{"key":"10.1016\/j.ymthe.2026.06.018_bib35","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/ana.410170409","article-title":"The cherry-red spot in Tay-Sachs and other storage diseases","volume":"17","author":"Kivlin","year":"1985","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ymthe.2026.06.018_bib36","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1136\/bjo.57.7.514","article-title":"Ocular pathology of GM2 gangliosidosis--Type 2 (Sandhoff\u2019s disease)","volume":"57","author":"Garner","year":"1973","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.ymthe.2026.06.018_bib37","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ymgme.2021.08.009","article-title":"Natural history of Tay-Sachs disease in sheep","volume":"134","author":"Story","year":"2021","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymthe.2026.06.018_bib38","doi-asserted-by":"crossref","first-page":"3670","DOI":"10.1038\/s41598-022-07612-7","article-title":"Natural history of retinal degeneration in ovine models of CLN5 and CLN6 neuronal ceroid lipofuscinoses","volume":"12","author":"Murray","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2026.06.018_bib39","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1463-5224.2007.00527.x","article-title":"Neuronal ceroid lipofuscinosis: clinical and morphologic findings in nine affected Polish Owczarek Nizinny (PON) dogs","volume":"10","author":"Narfstr\u00f6m","year":"2007","journal-title":"Vet. Ophthalmol."},{"key":"10.1016\/j.ymthe.2026.06.018_bib40","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/00006982-198600630-00009","article-title":"ULTRASTRUCTURE OF RETINAL PIGMENT EPITHELIAL AND NEURAL CELLS IN THE NEURONAL CEROID-LIPOFUSCINOSIS AFFECTED DALMATIAN DOG","volume":"6","author":"Goebel","year":"1986","journal-title":"Retina"},{"key":"10.1016\/j.ymthe.2026.06.018_bib41","first-page":"991","article-title":"Feline mucopolysaccharidosis VI: General ocular and pigment epithelial pathology","volume":"24","author":"Aguirre","year":"1983","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2026.06.018_bib42","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.3390\/vetsci12111078","article-title":"Retinal Function Deficits in American Staffordshire Terriers with a Late-Onset Neurodegenerative Disease Associated with an ARSG Variant","volume":"12","author":"Kick","year":"2025","journal-title":"Vet. Sci."},{"key":"10.1016\/j.ymthe.2026.06.018_bib43","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1159\/000127831","article-title":"Involvement of Retinal Neurons and Pigment Epithelial Cells in a Murine Model of Sandhoff Disease","volume":"40","author":"Sango","year":"2008","journal-title":"Ophthalmic Res."},{"key":"10.1016\/j.ymthe.2026.06.018_bib44","article-title":"A Protocol to Evaluate and Quantify Retinal Pigmented Epithelium Pathologies in Mouse Models of Age-Related Macular Degeneration","volume":"64927","author":"Landowski","year":"2023","journal-title":"JoVE"},{"key":"10.1016\/j.ymthe.2026.06.018_bib45","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1126\/science.1105681","article-title":"Axonopathy and transport deficits early in the pathogenesis of Alzheimer\u2019s disease","volume":"307","author":"Stokin","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2026.06.018_bib46","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1093\/brain\/awn312","article-title":"Severely dystrophic axons at amyloid plaques remain continuous and connected to viable cell bodies","volume":"132","author":"Adalbert","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.ymthe.2026.06.018_bib47","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.expneurol.2004.03.002","article-title":"Axonal dystrophy of dorsal root ganglion sensory neurons in a mouse model of Niemann-Pick disease type C","volume":"187","author":"Ohara","year":"2004","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ymthe.2026.06.018_bib48","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s004010050857","article-title":"Pathological study of mice with total deficiency of sphingolipid activator proteins (SAP knockout mice)","volume":"96","author":"Oya","year":"1998","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.ymthe.2026.06.018_bib49","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jns.2005.03.028","article-title":"Neuroprotective strategies in MS: lessons from C57BL\/Wld(S) mice","volume":"233","author":"Coleman","year":"2005","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.ymthe.2026.06.018_bib50","doi-asserted-by":"crossref","first-page":"10444","DOI":"10.1074\/jbc.M413863200","article-title":"Neuritic beading induced by activated microglia is an early feature of neuronal dysfunction toward neuronal death by inhibition of mitochondrial respiration and axonal transport","volume":"280","author":"Takeuchi","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymthe.2026.06.018_bib51","doi-asserted-by":"crossref","first-page":"14489","DOI":"10.1073\/pnas.0701311104","article-title":"Essential role for autophagy protein Atg7 in the maintenance of axonal homeostasis and the prevention of axonal degeneration","volume":"104","author":"Komatsu","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2026.06.018_bib52","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/ICU.0b013e32831215c3","article-title":"Ocular manifestation of storage diseases","volume":"19","author":"Biswas","year":"2008","journal-title":"Curr. Opin. Ophthalmol."},{"key":"10.1016\/j.ymthe.2026.06.018_bib53","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0140-6736(17)31868-8","article-title":"Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65 -mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial","volume":"390","author":"Russell","year":"2017","journal-title":"The Lancet"},{"key":"10.1016\/j.ymthe.2026.06.018_bib54","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.ymthe.2019.11.012","article-title":"A Safe and Reliable Technique for CNS Delivery of AAV Vectors in the Cisterna Magna","volume":"28","author":"Taghian","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.06.018_bib55","first-page":"4099","article-title":"Retinal Ganglion Cell Gene Transfer Is Achieved Following Intrathecal Administration of AAV9","volume":"58","author":"Gray","year":"2017","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2026.06.018_bib56","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1038\/sj.gt.3303029","article-title":"Systemic AAV-9 transduction in mice is influenced by animal age but not by the route of administration","volume":"14","author":"Bostick","year":"2007","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2026.06.018_bib57","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0061618","article-title":"A single intravenous AAV9 injection mediates bilateral gene transfer to the adult mouse retina","volume":"8","author":"Bemelmans","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2026.06.018_bib58","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/mt.2014.181","article-title":"The expression pattern of systemically injected AAV9 in the developing mouse retina is determined by age","volume":"23","author":"Byrne","year":"2015","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.06.018_bib59","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1089\/hum.2017.037","article-title":"Retro-Orbital Venous Sinus Delivery of rAAV9 Mediates High-Level Transduction of Brain and Retina Compared with Temporal Vein Delivery in Neonatal Mouse Pups","volume":"28","author":"Gruntman","year":"2017","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2026.06.018_bib60","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1096\/fj.11-182311","article-title":"Intravenous administration of AAV2\/9 to the fetal and neonatal mouse leads to differential targeting of CNS cell types and extensive transduction of the nervous system","volume":"25","author":"Rahim","year":"2011","journal-title":"FASEB J."},{"key":"10.1016\/j.ymthe.2026.06.018_bib61","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1094279","article-title":"Immune transgene-dependent myocarditis in macaques after systemic administration of adeno-associated virus expressing human acid alpha-glucosidase","volume":"14","author":"Hordeaux","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2026.06.018_bib62","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.omtm.2022.03.016","article-title":"eB transduces both the inner and outer retina with high efficacy in mice","volume":"25","author":"Palfi","year":"2022","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2026.06.018_bib63","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.exer.2010.08.011","article-title":"Transduction of the inner mouse retina using AAVrh8 and AAVrh10 via intravitreal injection","volume":"91","author":"Giove","year":"2010","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.ymthe.2026.06.018_bib64","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.931523","article-title":"Cerebrospinal fluid dynamics along the optic nerve","volume":"13","author":"Sheng","year":"2022","journal-title":"Front. Neurol."},{"key":"10.1016\/j.ymthe.2026.06.018_bib65","doi-asserted-by":"crossref","DOI":"10.1111\/cns.14919","article-title":"Evaluation of neuroretina following i.v. or intra-CSF AAV9 gene replacement in mice with MPS IIIA, a childhood dementia","volume":"30","author":"Beard","year":"2024","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.ymthe.2026.06.018_bib66","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.omtm.2020.12.014","article-title":"Intracranial delivery of AAV9 gene therapy partially prevents retinal degeneration and visual deficits in CLN6-Batten disease mice","volume":"20","author":"White","year":"2021","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2026.06.018_bib67","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/00061198-200308000-00003","article-title":"Estimating Normal Optic Nerve Axon Numbers in Non-Human Primate Eyes","volume":"12","author":"Cull","year":"2003","journal-title":"J. Glaucoma"},{"key":"10.1016\/j.ymthe.2026.06.018_bib68","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/IJG.0b013e3181405d4f","article-title":"Rodent models for glaucoma retinopathy and optic neuropathy","volume":"16","author":"Pang","year":"2007","journal-title":"J. Glaucoma"},{"key":"10.1016\/j.ymthe.2026.06.018_bib69","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1002\/cne.22333","article-title":"Topography of ganglion cells and photoreceptors in the sheep retina","volume":"518","author":"Shinozaki","year":"2010","journal-title":"J. Comp. Neurol."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626004958?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626004958?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T15:20:31Z","timestamp":1788362431000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001626004958"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":69,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S1525001626004958"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.06.018","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cerebrospinal delivery of a bidirectional AAV9 vector improves optic nerve and retinal pathology in a sheep model of Tay-Sachs disease","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.06.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}